Blog: 505(b)(2): What You Need to Know
In recent years 505(b)(2) approvals have experienced double-digit growth. Many companies are...
In recent years 505(b)(2) approvals have experienced double-digit growth. Many companies are...
Increasing prevalence of drug misuse and abuse is driving a heightened and more stringent approach...
WILMINGTON, NC – May 21, 2020 – Alcami, a North Carolina-based contract development and...
WILMINGTON, NC – MAY 18, 2020 – Alcami, a North Carolina-based contract development and...
As a contract manufacturer, Alcami provides experience in all aspects of the manufacturing process,...
Signed into law on January 4, 1983, the Orphan Drug Act (ODA) allows for granting special status to...
WOODCLIFF LAKE, N.J. —April 16, 2020— Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”), a New...
Even well-designed product formulations can fail if it is contained in inappropriate packaging. How...
Alcami’s end-to-end analytical testing platform supports clients’ programs through every stage of a
A Full-Time Equivalent (FTE) agreement is a comprehensive analytical service that grants...
Transaction Advances Alcami’s Strategic Plan by Adding Scale in Attractive and Growing Parenteral...
Name: Katie Shupe
Alcami Site: St. Louis, MO
What is your role?
I am a lead chemistry analyst. I...
Durham, NC (USA) – December 17, 2019 – Alcami Corporation, a leading provider of fully-integrated...
Name: Norman Chieng, PhD
Alcami Site: Charleston, SC
What is your role? I am a senior scientist in...
There are three main types of packaging – primary, secondary, and tertiary – and it is important to...
Durham, NC (USA) – October 8, 2019 – Alcami Corporation, a leading provider of fully-integrated...
Supporting a compound from discovery to clinical phases and potentially commercial phases requires...
Stability testing is a fundamental part of the drug development process— upholding the quality of...
According to Dr. John Metcalfe, “pharmaceutical companies go to great lengths to manufacture a drug...
The US Orphan Drug Act of 1983 characterizes an orphan disease as a rare medical condition that...